The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Mounjaro and Appendicitis — What the Evidence Shows
Appendicitis is inflammation of the appendix, a small tube-shaped organ in the lower right abdomen. Some people taking Mounjaro (tirzepatide) have reported abdominal pain, raising questions about whether the medication increases appendicitis risk. This guide explains what clinical evidence shows about Mounjaro and appendicitis, how to recognise warning signs, and when to seek urgent medical help. Always consult your GP if you experience severe abdominal pain while taking any medication.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
What Clinical Evidence Shows About Mounjaro and Appendicitis Risk
Mounjaro is a dual GIP and GLP-1 receptor agonist approved in the UK for weight management in adults. During clinical trials (SURMOUNT studies), appendicitis was not identified as a significant safety concern. However, Mounjaro can cause gastrointestinal side effects including nausea, constipation, diarrhoea, and abdominal discomfort — which are separate from appendicitis risk.
The MHRA (UK medicines regulator) has not issued any specific warnings linking tirzepatide to increased appendicitis risk. Appendicitis itself is relatively rare in the general population (approximately 7 cases per 10,000 people per year in the UK). If appendicitis does occur, it is typically not causally linked to weight loss medication, but rather develops independently.
That said, because Mounjaro affects how the digestive system works by slowing gastric emptying, it is important to distinguish between common GLP-1 side effects and signs of a serious abdominal condition. Your prescriber will have assessed your suitability for this medication during your clinical assessment.
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
How to Recognise Appendicitis vs. Mounjaro Side Effects
Common Mounjaro side effects include mild to moderate stomach pain, nausea, and constipation that typically improve within days or weeks as your body adjusts. These usually resolve on their own or with dietary changes.
Appendicitis warning signs require urgent medical attention: severe, sharp pain in the lower right abdomen; pain that worsens over hours; fever; nausea and vomiting alongside the pain; inability to eat or drink. If you experience these symptoms, call your GP immediately or attend A&E. Do not wait to see if the pain resolves.
Always report new or worsening abdominal pain to your GP or prescriber. They can assess whether symptoms are related to Mounjaro adjustment or require further investigation. Your GP can examine you and, if necessary, arrange imaging (ultrasound or CT scan) to rule out appendicitis or other serious conditions.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
Does Mounjaro cause appendicitis?
No direct causal link has been established between tirzepatide (Mounjaro) and appendicitis risk. Clinical trials did not identify appendicitis as a safety concern. However, Mounjaro can cause abdominal discomfort as a common side effect, which may be confused with other abdominal conditions. If you experience severe abdominal pain, seek urgent medical advice.
What abdominal pain is normal when starting Mounjaro?
Mild to moderate stomach pain, often alongside nausea, is a very common side effect affecting more than 1 in 10 people. This typically improves within days or weeks as your body adjusts. Pain should be manageable and intermittent. Severe, persistent pain spreading to the back or accompanied by fever requires urgent medical assessment.
When should I go to A&E with abdominal pain on Mounjaro?
Seek urgent care if you experience: sudden severe pain in the lower right abdomen; pain worsening rapidly over hours; fever above 38°C; persistent vomiting; inability to keep food or fluids down; or pain unrelieved by rest. Do not assume it is a Mounjaro side effect — let medical professionals assess you.
Should I stop taking Mounjaro if I develop abdominal pain?
Do not stop without speaking to your prescriber first. Report the pain to your GP or the service that prescribed your Mounjaro. They can assess whether the pain is a known side effect, adjust your dose, or arrange tests to rule out other conditions. Never self-manage by stopping prescription medication.
Can I take Mounjaro if I have had appendicitis before?
Having had appendicitis removed in the past is not a contraindication to Mounjaro, as your appendix can no longer become inflamed. However, always disclose your full medical history to your prescriber during your clinical assessment. They will assess your suitability based on your individual health profile and any other GI conditions.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.